| 1. |
- Gunnarsson, Peter, 1977-, et al.
(författare)
-
α1-acid glycoprotein (AGP)-induced platelet shape change involvesthe Rho/Rho kinase signalling pathway
- 2009
-
Ingår i: Thrombosis and Haemostasis. - Stuttgart, Germany : Schattauer Gmbh. - 0340-6245 .- 2567-689X. ; 102:4, s. 694-703
-
Tidskriftsartikel (refereegranskat)abstract
- α1-acid glycoprotein (AGP) is an acute-phase protein that contributes to inflammation processes. The role of AGP in platelet activation and thrombosis is, however, largely unknown. Therefore, we thoroughly investigated the effects of AGP on human platelets. Platelets were isolated from healthy volunteers and subsequently exposed to AGP. Platelet responses were monitored as change in light transmission, intracellular calcium concentration, light microscopy and protein phosphorylation by Western blot. We found that AGP induced platelet shape change independently of a second release of adenine nucleotides or thromboxane A2, and that effect was abolished by endotheliumderived platelet inhibitors such as nitric oxide (NO) and adenosine. Furthermore, AGP triggered a minor calcium response and a pronounced Rho/Rho-kinase-dependent increase in Thr696 phosphorylation of myosin phosphatase target subunit 1 (MYPT1). Moreover, the Rho/Rho-kinase inhibitor Y-27632 significantly decreased the AGP-induced shape change. The results also showed that the AGP-elicited shape change was antagonised by pretreatment with low doses of collagen and thrombospondin- 1. Our results describe a novel mechanism by which AGP stimulates platelet shape change via activation of the Rho/Rhokinase signalling pathway. Physiological important platelet inhibitors, such as NO, completely counterbalance the effect of AGP. Hence, the present study indicates that AGP directly contributes to platelet activation, which in turn might have an impact in physiological haemostasis and/or pathological thrombosis.
|
|
| 2. |
- Albertsson, Eva, 1979, et al.
(författare)
-
Proteomic analyses indicate induction of hepatic carbonyl reductase/20beta-hydroxysteroid dehydrogenase B in rainbow trout exposed to sewage effluent.
- 2007
-
Ingår i: Ecotoxicology and environmental safety. - : Elsevier BV. - 0147-6513. ; 68:1, s. 33-9
-
Tidskriftsartikel (refereegranskat)abstract
- Proteomic analyses were performed to identify regulated liver proteins in rainbow trout (Oncorhynchus mykiss) caged upstream and downstream from a sewage treatment works (STW). Two-dimensional gel electrophoresis, image analysis and FT-ICR mass-spectrometry revealed four regulated protein spots. The three down-regulated spots contained betaine aldehyde dehydrogenase, lactate dehydrogenase and an unidentified protein respectively. The only up-regulated spot consisted of both mitochondrial ATP synthase alpha-subunit and carbonyl reductase/20beta-hydroxysteroid dehydrogenase (CR/20beta-HSD). Further studies using quantitative PCR revealed a 13.5-fold induction of CR/20beta-HSD B mRNA following STW effluent exposure. The CR/20beta-HSD B gene was not regulated by 17alpha-ethinylestradiol, suggesting that its induction downstream from the STW is due to other factors than exposure to estrogens. Image analysis was initially performed on four gels from each group. These analyses suggested 15 regulated spots. However, validation of the 15 spots by increasing the number of replicates confirmed only four regulated spots. Hence, the present study also demonstrates the need for sufficient biological/technical replication in the interpretation of proteomic data.
|
|
| 3. |
|
|
| 4. |
|
|
| 5. |
- Asplund Persson, Anna, 1966-, et al.
(författare)
-
Dual actions of dephostatin on the nitric oxide/cGMP-signalling pathway in porcine iliac arteries
- 2005
-
Ingår i: European Journal of Pharmacology. - : Elsevier BV. - 0014-2999 .- 1879-0712. ; 521:1-3, s. 124-132
-
Tidskriftsartikel (refereegranskat)abstract
- We examined the effects of the nitrosoamine dephostatin on the nitric oxide (NO)/cyclic guanosine 3′,5′-monophosphate (cGMP)-signalling in porcine iliac arteries. Dephostatin has been characterised as a tyrosine phosphatase inhibitor, but Western blot analyses showed that dephostatin did not augment tyrosine phosphorylation of arterial proteins. However, dephostatin relaxed pre-contracted arteries, and this effect was antagonised by the soluble guanylyl cyclase inhibitor 1H[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ). Furthermore, dephostatin increased the cGMP content and the serine phosphorylation of vasodilator-stimulated phosphoprotein. Dephostatin also inhibited the relaxation induced by acetylcholine and the NO-donor S-nitroso-N-acetyl-penicillamine (SNAP). In contrast, dephostatin did not affect the NO-dependent actions of 1,2,3,4-Oxatriazolium, 3-(3-chloro-2-metylphenyl)-5-[[(4methylphenyl)sulfonyl]amino]-hydroxide inner salt (GEA 3175). Measurement of NO revealed that dephostatin accelerated the consumption of NO. In conclusion, dephostatin exerts dual effects on the NO/cGMP-signalling pathway in iliac arteries. The drug actions included scavenging of NO, but also stimulation of cGMP production. These effects were not related to inhibition of tyrosine phosphatases.
|
|
| 6. |
- Gunnarsson, Niklas, et al.
(författare)
-
Diffusion-Based 3D Motion Estimation from Sparse 2D Observations
- 2023
-
Annan publikation (övrigt vetenskapligt/konstnärligt)abstract
- Intra-interventional imaging is a tool for monitoring and guiding ongoing treatment sessions. Ideally one would like the full 3D image at high temporal resolution, this is however not possible due to the acquisition time. In this study, we consider the scenario when the observations are sparse and consist only of 2D image slices through the 3D volume. Given 2D-2D image registrations between a predefined 3D volume and the observations, we propose a method to estimate the full 3D motion. This 3D motion enables the reconstruction of the 3D anatomy. Our method relies on a conditioning-based denoising diffusion model and generates estimates given the 2D sparse observations. We reduce the dimensionality of the diffusion process by embedding the data in a lower dimensional space using principal component analysis. The model is evaluated in two experiments: first on synthetically generated data and then using medical lung images. Our observations show that the estimates are stable across the entire volume and within 1 mm of the lower bound defined by the reconstruction error.
|
|
| 7. |
|
|
| 8. |
- Gunnarsson, Niklas, et al.
(författare)
-
Online learning in motion modeling for intra-interventional image sequences
- 2024
-
Konferensbidrag (refereegranskat)abstract
- Image monitoring and guidance during medical examinations can aid both diagnosis and treatment. However, the sampling frequency is often too low, which creates a need to estimate the missing images. We present a probabilistic motion model for sequential medical images, with the ability to both estimate motion between acquired images and forecast the motion ahead of time. The core is a low-dimensional temporal process based on a linear Gaussian state-space model with analytically tractable solutions for forecasting, simulation, and imputation of missing samples. The results, from two experiments on publicly available cardiac datasets, show reliable motion estimates and an improved forecasting performance using patient-specific adaptation by online learning.
|
|
| 9. |
- Gunnarsson, Niklas, et al.
(författare)
-
Unsupervised dynamic modeling of medical image transformations
- 2022
-
Ingår i: 2022 25th International Conference on Information Fusion (FUSION 2022). - : Institute of Electrical and Electronics Engineers (IEEE). - 9781737749721 - 9781665489416 ; , s. 1-7
-
Konferensbidrag (refereegranskat)abstract
- Spatiotemporal imaging has applications in e.g. cardiac diagnostics, surgical guidance, and radiotherapy monitoring, In this paper, we explain the temporal motion by identifying the underlying dynamics, only based on the sequential images. Our dynamical model maps the inputs of observed high-dimensional sequential images to a low-dimensional latent space wherein a linear relationship between a hidden state process and the lower-dimensional representation of the inputs holds. For this, we use a conditional variational auto-encoder (CVAE) to nonlinearly map the higher dimensional image to a lower-dimensional space, wherein we model the dynamics with a linear Gaussian state-space model (LG-SSM). The model, a modified version of the Kalman variational auto-encoder, is end-to-end trainable, and the weights, both in the CVAE and LG-SSM, are simultaneously updated by maximizing the evidence lower bound of the marginal likelihood. In contrast to the original model, we explain the motion with a spatial transformation from one image to another. This results in sharper reconstructions and the possibility of transferring auxiliary information, such as segmentation, through the image sequence. Our experiments, on cardiac ultrasound time series, show that the dynamic model outperforms traditional image registration in execution time, to a similar performance. Further, our model offers the possibility to impute and extrapolate for missing samples.
|
|
| 10. |
- Gunnarsson, Peter, 1977-
(författare)
-
α1-acid glycoprotein modulates the function of human neutrophils and platelets
- 2009
-
Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
- The acute-phase protein α1-acid glycoprotein (AGP; orosomucoid) was initially identified andcharacterised in the 1950s. The normal plasma concentration is around 0.5-1 mg/ml butduring inflammation the concentration increase several fold and the carbohydrate compositionof the protein changes. AGP is a highly glycosylated protein with 45 % of the molecularweight consisting of glycans. These glycans are believed to be of importance for the functionof the protein. However, the precise physiological role of AGP is still unclear.The present thesis reveals that AGP at physiological concentration induce calcium elevationin human neutrophils and platelets. In neutrophils this response was enhanced several fold ifsurface L-selectin was pre-engaged. Our results showed that this L-selectin-mediatedamplification was abolished if the neutrophils were pre-treated with Src or phosphoinositide3-kinase (PI3K) inhibitors. AGP alone did not induce production of reactive oxygen species(ROS) in neutrophils. However, if the neutrophils were activated by the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine (fMLP) a subsequent addition of AGP caused aprominent ROS response. Moreover, both the calcium rise and the ROS response weredepending on sialic acid residues on AGP. In the case of calcium elevation we defined thereceptor as sialic-acid-binding immunoglobulin-like lectin (Siglec)-5 on the neutrophil.In platelets, AGP induced a Rho-kinase dependent phosphorylation of myosin phosphatasetarget subunit-1 (MYPT1) and a minor calcium response. This resulted in a prominent plateletshape change (i.e. spherical shape and granule centralization) recorded as change in lighttransmission and by differential interference contrast (DIC) microscopy. The shape changecaused by AGP was strongly suppressed by inhibition of Rho-kinase and abolished by Rhokinaseinhibition combined with chelation of intracellular calcium. No other manifestations ofplatelet activation like aggregation or secretion were registered. Opposite to neutrophils theeffect of AGP on platelets was not mediated by an interaction between sialic acid and siglecmolecules. However, the results indicated that AGP may bind to a collagen/thrombospondin-1surface receptor. Endogenous inhibitors like nitric oxide (NO) and adenosine abolished theAGP-induced platelet shape change. The antagonizing action of NO on shape change causedby AGP was long acting. In comparison, other aspects of agonist-induced platelet activation(e.g. intracellular calcium elevations) are only transiently suppressed by NO. This indicatesthat endothelium-derived NO may play a crucial role to counter balance the effect of AGP in vivo.Take together the results in this thesis reveal that AGP can initiate intracellular signalling andmodulate functional responses in neutrophils and platelets.
|
|
